Literature DB >> 137203

Lack of linkage between gene(s) controlling the synthesis of the seventh component of complement and the HLA region on chromosome No. 6 in man.

C Rittner, W Opferkuch, B Wellek, H Grosse-Wilde, P Wernet.   

Abstract

The family of an individual was studied who lacks the seventh component of complement in his serum (C7 homozygous deficiency). Both parents are C7 heterozygous-deficient. In this investigation, the following parameters were determined: complement components in functional and immunochemical tests; HLA-A,B antigens, HLA-D (MLC) determinants; the Bf system; glyoxalase I and B cell antigens. No evidence for linkage between the immunogenetic linkage group on chromosome 6 and gene(s) controlling the synthesis of the seventh component of complement was obtained. This is in according with the assumption that only genes controlling components of the initiating rather than the membrane attack unit of complement are linked to the HLA region.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 137203     DOI: 10.1007/bf00278881

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  Possible linkage of HL-A and GLO.

Authors:  W R Mayr; D Mayr; J Kömpf; S Bissbort; H Ritter
Journal:  Hum Genet       Date:  1976-02-29       Impact factor: 4.132

Review 2.  Genetic loci of components of the classical and alternate pathway of complement activation: a new dimension of the immunogenetic linkage group (HLA) on chromosome 6 in man.

Authors:  C Rittner
Journal:  Hum Genet       Date:  1976-12-29       Impact factor: 4.132

3.  Linkage of GLO with HLA and Bf. Effect of population and sex on recombination frequency.

Authors:  L R Weitkamp
Journal:  Tissue Antigens       Date:  1976-05

Review 4.  Human Ia-type alloantigens: methods of detection, aspects of chemistry and biology, markers for disease states.

Authors:  P Wernet
Journal:  Transplant Rev       Date:  1976

5.  Polymorphism of red cell glyoxalase I (EI: 4.4.1.5); a new genetic marker in man. Investigation of 169 mother-child combinations.

Authors:  J Kömpf; S Bissbort; S Gussmann; H Ritter
Journal:  Humangenetik       Date:  1975

6.  Linkage group HL-A-MLC-BF (properdin factor B). The site of the Bf locus at the immunogenetic linkage group on chromosome 6.

Authors:  C Rittner; H Grosse-Wilde; B Netzel; S Scholz; H Lorenz; E D Albert
Journal:  Humangenetik       Date:  1975

7.  A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.

Authors:  B Wellek; W Opferkuch
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

  7 in total
  6 in total

Review 1.  Genetic loci of components of the classical and alternate pathway of complement activation: a new dimension of the immunogenetic linkage group (HLA) on chromosome 6 in man.

Authors:  C Rittner
Journal:  Hum Genet       Date:  1976-12-29       Impact factor: 4.132

2.  Linkage for a locus of human complement C5 deficiency to the complement C6 structural locus.

Authors:  S I Rosenfeld; L R Weitkamp; J K Countryman
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

3.  Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.

Authors:  G R Nemerow; H Gewurz; S G Osofsky; T F Lint
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

4.  Linkage studies in hereditary angio-oedema.

Authors:  E B Robson; P J Lachmann; M J Hobart; A W Johnston
Journal:  J Med Genet       Date:  1979-10       Impact factor: 6.318

5.  Combined familial C7 and C4B deficiency in an adult with meningococcal disease.

Authors:  H M Chapel; T E Peto; G A Luzzi; R A Thompson; A H Fielder; J R Batchelor
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

6.  Genetic control of the eighth component of complement.

Authors:  D Raum; M A Spence; D Balavitch; S Tideman; A D Merritt; R T Taggart; B H Petersen; N K Day; C A Alper
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.